5 “Alternative” ETFs To Protect Against Losses – Or Make Money – Amid The Market Mayhem
For those investing for the long-term, the best thing to do in response to current market turmoil, driven by fears surrounding the novel coronavirus, may…
Stocks To Watch In March (Besides All Of Them)
“The final week of February swallowed up all of Wall Street’s year-to-date gains – and then some. Given this level of volatility, one could argue…
Consider Caterpillar Before It Comes Crawling Back
“Fewer than half of analysts who cover the stock recommend buying it. Consider doing so just the same,” advises the author of today’s article in…
Buy Tomorrow’s Dividend Aristocrats (Such As These 3 Stocks) At A Bargain Today
Dividend Aristocrats are great, but as the author of today’s article notes, “everyone already knows these firms are great. And as a result, their stocks…
Chasing After The No. 1 Stock Of 2020
What will end up being the best-performing stock of 2020? Nobody can say for sure. But looking at last year’s best-performing stocks may provide some…
Want To Protect Your Gains AND Your Upside Exposure? “Replace Rather Than Remove”!
If you’re sitting on shares with healthy profits and you want to protect your gains from a potential downturn, but you also want to maintain…
A Dozen Stocks With Attractive Growth AND Value Characteristics
Growth stocks have been the better performers in recent years. Meanwhile, when it comes to value investing, some have declared value dead, while others believe…
Which $1,000+ Stocks Are Worth The Price Of Admission?
Just five S&P 500 stocks trade for more than $1,000 a share. Among these five stocks are some well-known names (e.g. Amazon) and some lesser-known…
5 Undervalued Dividend Stocks For Investors Who Prefer Growing (As Opposed To The Highest) Yields
The five dividend-paying stocks highlighted in today’s article are not for dividend investors looking for the highest yields, but they are for dividend investors looking…
Epidemics, Pandemics & Portfolios
When it comes to the panic surrounding the novel coronavirus, the author of today’s article states “Because I am not an epidemiologist, I won’t opine…